Tiger Global led a USD150m Series C for Xendit, an Indonesia-based payments infrastructure provider for businesses, with follow-on from Accel, Amasia and Justin Kan’s Goat Capita, at a reported USD1b valuation. Read more… Read More
CDC Group, through its African Private Credit Fund Strategy, invested USD30m in Vantage Mezzanine Fund IV and committed USD30m to BluePeak Private Capital Fund I. Read more… Read More
SoftBank committed an additional USD3b to Latin American tech companies through its newly launched Latin America Fund 2. Read more… Read More
CX Partners and returning investor Jungle Ventures led a USD24m Series C for India-based workforce management platform BetterPlace, with participation from CDC Group and Capria Ventures, and follow-on from Unitus Ventures and 3one4 Capital. Read more… Read More
Quona Capital and MSA Capital led a USD33m Series A for Capiter, an Egypt-base B2B marketplace for the manufacturing industry, with participation from Savola, Shorooq Partners, Foundation Ventures, Accion Venture Lab and Derayah Ventures. Read more… Read More
Square Peg led a USD35m round for Pluang, an Indonesia-based fintech providing consumer savings and investment products, with participation from SIG and UOB Venture Management and follow-on from Go-Ventures and Openspace Ventures. This is an extension of the USD20m round led by Openspace Ventures in March. Read more… Read More
Kotak Special Situations Fund invested INR10b (~USD130m) in India-based logistics firm TVS Supply Chain Solutions. Of the INR10b, INR8b (~USD109m) were invested in the form of non-convertible debentures while the remaining INR2b (~USD27m) were invested in the form of equity. Read more… Read More
A fund managed by BTG Pactual invested BRL12.8b (~USD2.4b) for a 58% stake in Brazil-based fiber optic company V.tal. GIC recently invested BRL2.2b (~USD421m) in the fund. The deal is subject to regulatory approval. Read more… Read More
Monk’s Hill Ventures, Jungle Ventures and Alpha JWC Ventures invested an undisclosed pre-Series A for Indonesia-based digital identity network VIDA. Read more… Read More
3H Health Investment, Loyal Valley Capital and Morningside Ventures led a USD54.5m Series B+ for Alebund Pharmaceuticals, a China-based biopharmaceutical company developing treatment for renal diseases, with participation from YuanBio Venture Capital, Octagon Capital, Verition Fund Management and HT Capital, and follow-on from Lilly Asia Ventures, Quan Capital, 3E Bioventures… Read More
(default archive template)